12/23/2025
We are proud to announce Michael Foote, M.D. of Memorial Sloan Kettering Cancer Center, as the first-ever recipient of our new $150,000 ACPMP Changemaker Research Grant 🎗️
Dr. Foote has been awarded this 2-year, $150,000 grant for his research project titled, “Targeting the Surface Proteome of Appendiceal Cancer Peritoneal Metastasis."
This promising research will use state-of-the-art proteomics technology to define surface proteins specific to appendix cancer metastases and then expediently design targeted therapies using these proteins to deliver drugs directly to tumors, avoiding toxicity to healthy tissue.
The ACPMP Changemaker Grant Program was created to support high-impact scientific, clinical, and translational research with the highest potential to ultimately impact patients or potential to change what we know about and PMP to provide answers about this rare disease that will help to advance treatments for patients.
This research investment is made possible thanks to the generosity of our donors, whose support fuels critical advances in appendix cancer research.
ACPMP received a number of impressive research applications this cycle, and we thank all those who submitted. Thank you to our Scientific Advisory Board for their review and recommendations.
And congratulations, Dr. Foote!
